Thrombotic disorders: diagnosis and treatment

Area of Science:

• Hematology
• Thrombosis and Hemostasis

Background:

• Hematologists play a crucial role in diagnosing and managing thromboembolic disorders.
• Recent advances have improved understanding of hypercoagulability in thrombosis pathogenesis.
• This has led to new diagnostic approaches and antithrombotic strategies.

Purpose of the Study:

• To review current concepts of hypercoagulable states and their role in thrombosis.
• To discuss thrombosis management in specific patient populations, including those with cancer and during pregnancy.
• To examine perioperative anticoagulation management strategies.

Main Methods:

• Review of acquired and inherited hypercoagulable states.
• Discussion of thrombosis in cancer patients, focusing on treatment goals and new therapies.
• Analysis of thrombotic risks associated with pregnancy and hormonal therapy.
• Evaluation of anticoagulation management before and after elective surgery.

Main Results:

• Most venous thromboembolism patients have an underlying genetic thrombophilia.
• Acquired thrombogenic triggers precipitate clinical thrombosis.
• Outpatient therapy and low-molecular-weight heparin improve venous thromboembolism treatment in cancer patients.
• Risk stratification for thrombotic complications in pregnancy and hormonal therapy is essential.
• Different anticoagulation management approaches exist for patients on warfarin undergoing surgery.

Conclusions:

• Genetic thrombophilia and acquired triggers are central to thrombosis.
• Tailored antithrombotic strategies are crucial for diverse patient groups.
• Evidence-based management of anticoagulation is vital for surgical patients.